$ACT Recent Headlines U.S. stock market is start
Post# of 72741
Posted On: 02/24/2014 9:47:52 AM
$ACT Recent Headlines
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Today - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Forest Lab surges 27% premarket on Actavis deal 7:09 a.m. Feb. 18, 2014 - Silvia Ascarelli
Actavis confirms $25 bln Forest Labs acquistion 7:02 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis in talks to buy Forest Labs for up to $25 bln 1:06 a.m. Feb. 18, 2014 - Dana Mattioli, Jonathan D. Rockoff and Dana Cimilluca
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Should You Get Rid of WellCare (WCH) Now? - Tale of the Tape 49 min ago - Zacks.com
Why Markets Like The Current One Can Breed Bad Ideas 4:51 p.m. Feb. 21, 2014 - Investors Business Daily
Impax Posts Loss in 4Q - Analyst Blog 11:27 a.m. Feb. 21, 2014 - Zacks.com
Actavis Up on Strong 4Q Earnings Beat - Analyst Blog 9:46 a.m. Feb. 21, 2014 - Zacks.com
This Biotech Bubble Is Bound to Burst 3:28 a.m. Feb. 21, 2014 - InvestorPlace.com
Actavis PLC (ACT): Today's Featured Health Care Winner 5:00 p.m. Feb. 20, 2014 - TheStreet.com
Shares of M&A Bidders Enjoy Rare Burst of Buying 12:00 p.m. Feb. 20, 2014 - FOXBusiness
Actavis Q4 Beats Street; Guidance Affirmed For Now 10:21 a.m. Feb. 20, 2014 - Investors Business Daily
More on Actavis Q4: Warner Chilcott boosts revenue 8:44 a.m. Feb. 20, 2014 - Seeking Alpha
UPDATE: Actavis Posts Upbeat Q4 Earnings 7:48 a.m. Feb. 20, 2014 - benzinga.com
Actavis Swings to Loss on Restructuring, Write-Downs 7:33 a.m. Feb. 20, 2014 - WSJ.com
Notable earnings before Thursday’s open 12:05 a.m. Feb. 20, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Feb. 19, 2014 - Seeking Alpha
Is It Too Soon To Call 2014 A Year Of Mergers And Acquisitions? 5:18 p.m. Feb. 19, 2014 - TheStreet.com
Medicals Among Top 20 Groups, Retailers Near Bottom 5:07 p.m. Feb. 19, 2014 - Investors Business Daily
Top-Ranked Forest Labs Soars on Buyout News - Analyst Blog 3:45 p.m. Feb. 19, 2014 - Zacks.com
After Forest Deal, Actavis Could Climb 50% 10:53 a.m. Feb. 19, 2014 - Barrons.com
Stock Market News for February 19, 2014 - Market News 10:06 a.m. Feb. 19, 2014 - Zacks.com
Is Weather the Only Explanation? - Ahead of Wall Street 9:46 a.m. Feb. 19, 2014 - Zacks.com
The Market Rally Resembles a Dog On a Bone 5:59 a.m. Feb. 19, 2014 - InvestorPlace.com
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Today - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Forest buyout may not spell the end of dealmaking for Actavis 3:00 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Pharma ETFs pop on the Actavis-Forest deal 2:07 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Investors drive up price of Actavis-Forest deal 11:14 a.m. Feb. 18, 2014 - blogs.marketwatch.com
Actavis shares jump 7.8% on Forest Lab deal 9:35 a.m. Feb. 18, 2014 - Sue Chang
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis-Forest Labs is play on changes in health care 9:06 a.m. Feb. 18, 2014 - Dana Mattioli
Actavis confirms $25 bln Forest Labs acquistion 7:15 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis shares climb 10% on deal for Forest Labs 7:12 a.m. Feb. 18, 2014 - Silvia Ascarelli
Forest Lab surges 27% premarket on Actavis deal 7:09 a.m. Feb. 18, 2014 - Silvia Ascarelli
Actavis confirms $25 bln Forest Labs acquistion 7:02 a.m. Feb. 18, 2014 - Sara Sjolin
Actavis in talks to buy Forest Labs for up to $25 bln 1:06 a.m. Feb. 18, 2014 - Dana Mattioli, Jonathan D. Rockoff and Dana Cimilluca
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Should You Get Rid of WellCare (WCH) Now? - Tale of the Tape 49 min ago - Zacks.com
Why Markets Like The Current One Can Breed Bad Ideas 4:51 p.m. Feb. 21, 2014 - Investors Business Daily
Impax Posts Loss in 4Q - Analyst Blog 11:27 a.m. Feb. 21, 2014 - Zacks.com
Actavis Up on Strong 4Q Earnings Beat - Analyst Blog 9:46 a.m. Feb. 21, 2014 - Zacks.com
This Biotech Bubble Is Bound to Burst 3:28 a.m. Feb. 21, 2014 - InvestorPlace.com
Actavis PLC (ACT): Today's Featured Health Care Winner 5:00 p.m. Feb. 20, 2014 - TheStreet.com
Shares of M&A Bidders Enjoy Rare Burst of Buying 12:00 p.m. Feb. 20, 2014 - FOXBusiness
Actavis Q4 Beats Street; Guidance Affirmed For Now 10:21 a.m. Feb. 20, 2014 - Investors Business Daily
More on Actavis Q4: Warner Chilcott boosts revenue 8:44 a.m. Feb. 20, 2014 - Seeking Alpha
UPDATE: Actavis Posts Upbeat Q4 Earnings 7:48 a.m. Feb. 20, 2014 - benzinga.com
Actavis Swings to Loss on Restructuring, Write-Downs 7:33 a.m. Feb. 20, 2014 - WSJ.com
Notable earnings before Thursday’s open 12:05 a.m. Feb. 20, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Feb. 19, 2014 - Seeking Alpha
Is It Too Soon To Call 2014 A Year Of Mergers And Acquisitions? 5:18 p.m. Feb. 19, 2014 - TheStreet.com
Medicals Among Top 20 Groups, Retailers Near Bottom 5:07 p.m. Feb. 19, 2014 - Investors Business Daily
Top-Ranked Forest Labs Soars on Buyout News - Analyst Blog 3:45 p.m. Feb. 19, 2014 - Zacks.com
After Forest Deal, Actavis Could Climb 50% 10:53 a.m. Feb. 19, 2014 - Barrons.com
Stock Market News for February 19, 2014 - Market News 10:06 a.m. Feb. 19, 2014 - Zacks.com
Is Weather the Only Explanation? - Ahead of Wall Street 9:46 a.m. Feb. 19, 2014 - Zacks.com
The Market Rally Resembles a Dog On a Bone 5:59 a.m. Feb. 19, 2014 - InvestorPlace.com
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17 7:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Actavis to Present at Citi's 2014 Global Healthcare Conference 4:25 p.m. Feb. 19, 2014 - PR Newswire - PRF
Critical Alerts For Actavis, athenahealth, Seattle Genetics, JP Morgan Chase, and SodaStream Released By InvestorsObserver 9:31 a.m. Feb. 19, 2014 - PR Newswire - PRF
Actavis to buy Forest Labs for $25B and GT Advanced Tech acquires exclusive rights from Kyma Tech 12:31 a.m. Feb. 19, 2014 - ACCESSWIRE
Acquisition of Forest Laboratories, Inc. by Actavis plc May Not Be in Shareholders' Best Interests 9:02 p.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Cancel Q4 and FY 2013 Earnings Call Previously Scheduled for Thursday, February 20, 2014 5:13 p.m. Feb. 18, 2014 - PR Newswire - PRF
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Forest Laboratories, Inc. Stockholders 5:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Forest Labs Acquisition; Outlook Stable 2:52 p.m. Feb. 18, 2014 - BusinessWire - BZX
FOREST SHAREHOLDERS NOTICE:Johnson & Weaver, LLP Announces Investigation of the Forest Laboratories, Inc. Proposed Acquisition by Actavis plc 9:43 a.m. Feb. 18, 2014 - BusinessWire - BZX
INVESTOR BUYOUT ALERT - Offer to Acquire Forest Laboratories - Shareholder Rights Law Firm Tripp Levy PLLC Seeks Higher Price And More Information For Shareholders 8:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction 7:00 a.m. Feb. 18, 2014 - PR Newswire - PRF
Actavis to Host Fourth Quarter 2013 Earnings Conference Call and Webcast 8:00 a.m. Feb. 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Treanda® Patent Challenge 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
Actavis Presents Outlook for Continued Long-Term Growth 7:15 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Refocused Global Business Structure to Maximize Evolution into Global Specialty Pharmaceuticals Leadership 7:00 a.m. Jan. 31, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF
(0)
(0)